178 related articles for article (PubMed ID: 20043512)
21. Disseminated CD8-positive, CD30-positive cutaneous lymphoproliferative eruption with overlapping features of mycosis fungoides and primary cutaneous anaplastic large cell lymphoma following remote solitary lesional presentation.
Davick JJ; Mutgi KAJ; Wanat KA; Link BK; Liu V
J Cutan Pathol; 2017 Aug; 44(8):703-712. PubMed ID: 28497585
[TBL] [Abstract][Full Text] [Related]
22. Lymphomatoid papulosis, pityriasis lichenoides et varioliformis acuta, and anaplastic large-cell (Ki-1+) lymphoma.
Cerroni L
J Am Acad Dermatol; 1997 Aug; 37(2 Pt 1):287. PubMed ID: 9270525
[No Abstract] [Full Text] [Related]
23. CD30+ diseases: anaplastic large-cell lymphoma and lymphomatoid papulosis.
Borchmann P
Cancer Treat Res; 2008; 142():349-65. PubMed ID: 18283794
[No Abstract] [Full Text] [Related]
24. Contribution of longitudinal follow up and clinical pathological correlation in the diagnosis CD30-positive skin infiltrates.
De Souza A; Carter JB; Harris NL; Ferry JA; Duncan LM
J Cutan Pathol; 2015 Jul; 42(7):452-8. PubMed ID: 25931140
[TBL] [Abstract][Full Text] [Related]
25. A comparison of clinical, morphological and immunohistochemical features of lymphomatoid papulosis and primary cutaneous CD30(Ki-1)-positive anaplastic large cell lymphoma.
Tomaszewski MM; Lupton GP; Krishnan J; May DL
J Cutan Pathol; 1995 Aug; 22(4):310-8. PubMed ID: 7499570
[TBL] [Abstract][Full Text] [Related]
26. Primary cutaneous CD30+ lymphoproliferative disorders: new insights into biology and therapy.
Querfeld C; Kuzel TM; Guitart J; Rosen ST
Oncology (Williston Park); 2007 May; 21(6):689-96; discussion 699-700,. PubMed ID: 17564326
[TBL] [Abstract][Full Text] [Related]
27. Lymphoma- and leukemia-associated cutaneous atypical CD30+ T-cell reactions.
Su LD; Duncan LM
J Cutan Pathol; 2000 May; 27(5):249-54. PubMed ID: 10847550
[TBL] [Abstract][Full Text] [Related]
28. Primary cutaneous CD30-positive lymphoproliferative disorders.
Willemze R; Meijer CJ
Hematol Oncol Clin North Am; 2003 Dec; 17(6):1319-32, vii-viii. PubMed ID: 14710887
[TBL] [Abstract][Full Text] [Related]
29. Fascin expression in CD30-positive cutaneous lymphoproliferative disorders.
Kempf W; Levi E; Kamarashev J; Kutzner H; Pfeifer W; Petrogiannis-Haliotis T; Burg G; Kadin ME
J Cutan Pathol; 2002 May; 29(5):295-300. PubMed ID: 12100631
[TBL] [Abstract][Full Text] [Related]
30. CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma.
Liu HL; Hoppe RT; Kohler S; Harvell JD; Reddy S; Kim YH
J Am Acad Dermatol; 2003 Dec; 49(6):1049-58. PubMed ID: 14639383
[TBL] [Abstract][Full Text] [Related]
31. Pediatric oral Epstein-Barr virus associated self-remitting CD30+ lymphoproliferative disorder: A distinct entity.
Schwartz Z; Bowe RB; Coleman M; Magro CM
Ann Diagn Pathol; 2018 Dec; 37():57-61. PubMed ID: 30292067
[TBL] [Abstract][Full Text] [Related]
32. CD30+ lymphoproliferative disorder in a patient with metastatic papillary thyroid carcinoma.
Udkoff J; Cohen PR
Dermatol Online J; 2016 Oct; 22(10):. PubMed ID: 28329586
[TBL] [Abstract][Full Text] [Related]
33. [Cutaneous neutrophils infiltrates. Case 7. Lymphomatoid papulosis].
Vergier B
Ann Pathol; 2011 Jun; 31(3):198-202. PubMed ID: 21737002
[No Abstract] [Full Text] [Related]
34. Type A lymphomatoid papulosis presenting as an eyelid ulcer in a young man.
Sánchez España JC; Secondi R
Orbit; 2019 Dec; 38(6):495-499. PubMed ID: 30644803
[TBL] [Abstract][Full Text] [Related]
35. Toll-like receptor 2, 4, 7 and 9 expression in primary cutaneous CD30+ T-cell lymphoma.
Knol AC; Ehst BD; Dompmartin A; Quéreux G; Nguyen JM; Comoz F; Renaut JJ; Khammari A; Vonderheid EC; Dréno B
Br J Dermatol; 2009 Dec; 161(6):1414-6. PubMed ID: 19785598
[No Abstract] [Full Text] [Related]
36. Perils and pitfalls regarding differential diagnosis and treatment of primary cutaneous anaplastic large-cell lymphoma.
Diamantidis MD; Myrou AD
ScientificWorldJournal; 2011 May; 11():1048-55. PubMed ID: 21552770
[TBL] [Abstract][Full Text] [Related]
37. CD30+ lymphoproliferative disorder with spindle-cell morphology.
Martires KJ; Cohen BE; Cassarino DS
J Cutan Pathol; 2016 Nov; 43(11):1041-1044. PubMed ID: 27433975
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous CD30-positive T-cell lymphoproliferative disorders-clinical and histopathologic features, differential diagnosis, and treatment.
Kempf W; Kerl K; Mitteldorf C
Semin Cutan Med Surg; 2018 Mar; 37(1):24-29. PubMed ID: 29719017
[TBL] [Abstract][Full Text] [Related]
39. Primary cutaneous CD30 positive T-cell lymphoproliferative disorders with aberrant expression of PAX5: report of three cases.
Hagiwara M; Tomita A; Takata K; Shimoyama Y; Yoshino T; Tomita Y; Nakamura S
Pathol Int; 2012 Apr; 62(4):264-70. PubMed ID: 22449230
[TBL] [Abstract][Full Text] [Related]
40. Recurrent course and CD30 expression of atypical T lymphocytes distinguish lymphomatoid papulosis from primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma.
Tsujiwaki M; Abe R; Ohguchi Y; Hoshina D; Murata J; Fujita Y; Nomura T; Ambo M; Shimizu H
Acta Derm Venereol; 2014 Sep; 94(5):613-4. PubMed ID: 24549273
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
